menu
    • menu
    [{"orgOrder":0,"company":"Wanbury Limited","sponsor":"Cipla","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"INDIA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2020","type":"Acquisition","leadProduct":"Folic Acid","moa":"||Folate receptor (FOLR)","graph1":"Hematology","graph2":"Approved FDF","graph3":"Wanbury Limited","amount2":0.01,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Hematology","amount2New":0.01,"dosageForm":"Tablet","sponsorNew":"Wanbury Limited \/ Cipla","highestDevelopmentStatusID":"15","companyTruncated":"Wanbury Limited \/ Cipla"},{"orgOrder":0,"company":"Hangzhou Agile Groups Network Technology Co., Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"CHINA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2025","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Hematology","graph2":"Undisclosed","graph3":"Hangzhou Agile Groups Network Technology Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Hangzhou Agile Groups Network Technology Co., Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Hangzhou Agile Groups Network Technology Co., Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"Centre Fran\u00e7ois Baclesse","sponsor":"Pfizer Inc | F. Hoffmann-La Roche | CSL Vifor","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"FRANCE","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Oncology","graph2":"Phase IV","graph3":"Centre Fran\u00e7ois Baclesse","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Centre Fran\u00e7ois Baclesse \/ Pfizer Inc | F. Hoffmann-La Roche | CSL Vifor","highestDevelopmentStatusID":"11","companyTruncated":"Centre Fran\u00e7ois Baclesse \/ Pfizer Inc | F. Hoffmann-La Roche | CSL Vifor"},{"orgOrder":0,"company":"Ume\u00e5 University","sponsor":"University of California | Mead Johnson Nutrition","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"SWEDEN","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Ume\u00e5 University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ume\u00e5 University \/ University of California | Mead Johnson Nutrition","highestDevelopmentStatusID":"1","companyTruncated":"Ume\u00e5 University \/ University of California | Mead Johnson Nutrition"},{"orgOrder":0,"company":"CSL Vifor","sponsor":"Worldwide Clinical Trials | Fresenius Medical Care","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"SWITZERLAND","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2017","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Hematology","graph2":"Undisclosed","graph3":"CSL Vifor","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"CSL Vifor \/ Worldwide Clinical Trials | Fresenius Medical Care","highestDevelopmentStatusID":"1","companyTruncated":"CSL Vifor \/ Worldwide Clinical Trials | Fresenius Medical Care"},{"orgOrder":0,"company":"Swiss Federal Institute of Technology","sponsor":"Danone Nutricia Research","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SWITZERLAND","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2019","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Swiss Federal Institute of Technology","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Swiss Federal Institute of Technology \/ Danone Nutricia Research","highestDevelopmentStatusID":"1","companyTruncated":"Swiss Federal Institute of Technology \/ Danone Nutricia Research"},{"orgOrder":0,"company":"Danone","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"FRANCE","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Iron","moa":"||Hemoglobin (HB)","graph1":"Hematology","graph2":"Approved FDF","graph3":"Danone","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Danone \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Danone \/ Undisclosed"},{"orgOrder":0,"company":"Bayer AG","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"GERMANY","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2025","type":"Inapplicable","leadProduct":"Iron","moa":"||Hemoglobin (HB)","graph1":"Hematology","graph2":"Approved FDF","graph3":"Bayer AG","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Gummies","sponsorNew":"Bayer AG \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Bayer AG \/ Undisclosed"},{"orgOrder":0,"company":"Western Galilee Hospital, Nahariya","sponsor":"Luoxis","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"ISRAEL","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Western Galilee Hospital, Nahariya","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Western Galilee Hospital, Nahariya \/ Luoxis","highestDevelopmentStatusID":"1","companyTruncated":"Western Galilee Hospital, Nahariya \/ Luoxis"},{"orgOrder":0,"company":"NICHD Global Network for Women's and Children's Health","sponsor":"Thomas Jefferson University | University of North Carolina, Chapel Hill | Kinshasa School of Public Health | University of Alabama at Birmingham | University Teaching Hospital, Lusaka, Zambia | University of Colorado, Denver | Institute of Nutrition of Ce","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Hematology","graph2":"Phase III","graph3":"NICHD Global Network for Women's and Children's Health","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"NICHD Global Network for Women's and Children's Health \/ Thomas Jefferson University | University of North Carolina, Chapel Hill | Kinshasa School of Public Health | University of Alabama at Birmingham | University Teaching Hospital, Lusaka, Zambia | University of Colorado, Denver | Institute of Nutrition of Ce","highestDevelopmentStatusID":"10","companyTruncated":"NICHD Global Network for Women's and Children's Health \/ Thomas Jefferson University | University of North Carolina, Chapel Hill | Kinshasa School of Public Health | University of Alabama at Birmingham | University Teaching Hospital, Lusaka, Zambia | University of Colorado, Denver | Institute of Nutrition of Ce"},{"orgOrder":0,"company":"Auerbach Hematology Oncology Associates P C","sponsor":"Pharmacosmos AS","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2014","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase II","graph3":"Auerbach Hematology Oncology Associates P C","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Auerbach Hematology Oncology Associates P C \/ Pharmacosmos AS","highestDevelopmentStatusID":"8","companyTruncated":"Auerbach Hematology Oncology Associates P C \/ Pharmacosmos AS"},{"orgOrder":0,"company":"Nova Scotia Health Authority","sponsor":"Capital Health, Canada | Dalhousie University","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2013","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Musculoskeletal","graph2":"Phase III","graph3":"Nova Scotia Health Authority","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nova Scotia Health Authority \/ Capital Health, Canada | Dalhousie University","highestDevelopmentStatusID":"10","companyTruncated":"Nova Scotia Health Authority \/ Capital Health, Canada | Dalhousie University"},{"orgOrder":0,"company":"UT Southwestern Medical Center","sponsor":"Gensavis Pharmaceuticals, LLC","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2013","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Hematology","graph2":"Phase IV","graph3":"UT Southwestern Medical Center","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"UT Southwestern Medical Center \/ Gensavis Pharmaceuticals, LLC","highestDevelopmentStatusID":"11","companyTruncated":"UT Southwestern Medical Center \/ Gensavis Pharmaceuticals, LLC"},{"orgOrder":0,"company":"Ferronova Pty Ltd","sponsor":"Royal Adelaide Hospital | Austin Health | Flinders Medical Centre | Peter MacCallum Cancer Centre | South Australian Health and Medical Research Institute","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"AUSTRALIA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Oncology","graph2":"Undisclosed","graph3":"Ferronova Pty Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Ferronova Pty Ltd \/ Royal Adelaide Hospital | Austin Health | Flinders Medical Centre | Peter MacCallum Cancer Centre | South Australian Health and Medical Research Institute","highestDevelopmentStatusID":"1","companyTruncated":"Ferronova Pty Ltd \/ Royal Adelaide Hospital | Austin Health | Flinders Medical Centre | Peter MacCallum Cancer Centre | South Australian Health and Medical Research Institute"},{"orgOrder":0,"company":"PharmaLinea","sponsor":"Clinres Farmacija","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2021","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Hematology","graph2":"Undisclosed","graph3":"PharmaLinea","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PharmaLinea \/ Clinres Farmacija","highestDevelopmentStatusID":"1","companyTruncated":"PharmaLinea \/ Clinres Farmacija"},{"orgOrder":0,"company":"Lubrizol","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2025","type":"Inapplicable","leadProduct":"Iron","moa":"Hemoglobin (HB)","graph1":"Hematology","graph2":"Preclinical","graph3":"Lubrizol","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Lubrizol \/ Undisclosed","highestDevelopmentStatusID":"4","companyTruncated":"Lubrizol \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for Iron

    Menu

    Iron

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Lubrizol

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            Lubrizol

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Study Phase : Preclinical

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Lubrizol's Iron Shows Superior Absorption in Preclinical Study

                            Details : Iron, a vital mineral, targets hemoglobin to combat iron deficiency anemia (IDA) in patients.

                            Product Name : Lipofer

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            October 14, 2025

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Highest Development Status : Preclinical

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Bayer AG

                            Germany arrow
                            ACI Convention
                            Not Confirmed

                            Bayer AG

                            Germany arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron,Ascorbic Acid,Vitamin D

                            Therapeutic Area : Hematology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            One A Day Launches First Multivitamin Gummy With Iron For Kids

                            Details : One A Day Kids Multi with Iron Gummies provides key nutrients and an excellent source of iron with 12mg of iron in two gummies a day

                            Product Name : One A Day Kids Multi with Iron Gummies

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            July 23, 2025

                            Lead Product(s) : Iron,Ascorbic Acid,Vitamin D

                            Therapeutic Area : Hematology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Hangzhou Agile Groups Network Technology Co., Ltd.

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            Hangzhou Agile Groups Network Technology Co., Ltd.

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency ...

                            Details : Iron is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            March 11, 2025

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Ferronova Pty Ltd

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            Ferronova Pty Ltd

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : Royal Adelaide Hospital | Austin Health | Flinders Medical Centre | Peter MacCallum Cancer Centre | South Australian Health and Medical Research Institute

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation

                            Details : Iron is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Stomach Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            June 12, 2023

                            Lead Product(s) : Iron

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : Royal Adelaide Hospital | Austin Health | Flinders Medical Centre | Peter MacCallum Cancer Centre | South Australian Health and Medical Research Institute

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            NICHD Global Network for Women's and Children's Health

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            NICHD Global Network for Women's and Children's Health

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Study Phase : Phase III

                            Sponsor : Thomas Jefferson University | University of North Carolina, Chapel Hill | Kinshasa School of Public Health | University of Alabama at Birmingham | University Teaching Hospital, Lusaka, Zambia | University of Colorado, Denver | Institute of Nutrition of Ce

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Prevention of Iron Deficiency Anemia Post-delivery

                            Details : Iron is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anemia, Postpartum.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            October 21, 2022

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Highest Development Status : Phase III

                            Sponsor : Thomas Jefferson University | University of North Carolina, Chapel Hill | Kinshasa School of Public Health | University of Alabama at Birmingham | University Teaching Hospital, Lusaka, Zambia | University of Colorado, Denver | Institute of Nutrition of Ce

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Danone

                            France arrow
                            ACI Convention
                            Not Confirmed

                            Danone

                            France arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron,DHA

                            Therapeutic Area : Hematology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            FDA Infant Formula Update: June 17, 2022

                            Details : Aptamil (Iron) First Infant Milk Stage 1(This infant formula is appropriate for most infants and meets U.S. nutrient requirements, but it may not be suitable for infants born prematurely, or with a low birth weight.

                            Product Name : Aptamil

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            June 17, 2022

                            Lead Product(s) : Iron,DHA

                            Therapeutic Area : Hematology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            PharmaLinea

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            PharmaLinea

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Sponsor : Clinres Farmacija

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of >Your< Iron Syrup Supplementation in Children With Dietary Iron Deficiency

                            Details : Iron is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Iron Deficiencies.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            January 19, 2021

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Sponsor : Clinres Farmacija

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Wanbury Limited

                            India arrow
                            ACI Convention
                            Not Confirmed

                            Wanbury Limited

                            India arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Folic Acid,Iron

                            Therapeutic Area : Hematology

                            Study Phase : Approved FDF

                            Sponsor : Cipla

                            Deal Size : $12.3 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Cipla acquires 4 key brands from Wanbury for up to Rs 89 crore.

                            Details : Cipla has acquired the four brands namely CPink, CDense, Productiv and Folinine to further strengthen its presence in the women's health segment, Cipla said in a filing to the BSE.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Undisclosed

                            February 07, 2020

                            Lead Product(s) : Folic Acid,Iron

                            Therapeutic Area : Hematology

                            Highest Development Status : Approved FDF

                            Sponsor : Cipla

                            Deal Size : $12.3 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Swiss Federal Institute of Technology

                            Country arrow
                            ACI Convention
                            Not Confirmed

                            Swiss Federal Institute of Technology

                            Country arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Danone Nutricia Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Iron Absorption From a Wheat-based Instant Cereal:Gut and Stable Isotope Studies in Kenyan Infants

                            Details : Iron is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            March 28, 2019

                            Lead Product(s) : Iron

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Danone Nutricia Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            CSL Vifor

                            Switzerland arrow
                            ACI Convention
                            Not Confirmed

                            CSL Vifor

                            Switzerland arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Sponsor : Worldwide Clinical Trials | Fresenius Medical Care

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (AC...

                            Details : Iron is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            July 11, 2017

                            Lead Product(s) : Iron

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Sponsor : Worldwide Clinical Trials | Fresenius Medical Care

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth